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a b s t r a c t
West Nile virus (WNV) is a mosquito-transmitted pathogen, which causes signiﬁcant disease in humans.
The innate immune system is a ﬁrst-line defense against invading microorganism and many ﬂaviviruses,
including WNV, have evolved multifunctional proteins, which actively suppress its activation and antiviral
actions. The WNV non-structural protein 1 (NS1) inhibits signal transduction originating from Toll-like
receptor 3 (TLR3) and also critically contributes to virus genome replication. In this study we developed a
novel FACS-based screen to attempt to separate these two functions. The individual amino acid changes
P320S and M333V in NS1 restored TLR3 signaling in virus-infected HeLa cells. However, virus replication
was also attenuated, suggesting that the two functions are not easily separated and may be contained
within overlapping domains. The residues we identiﬁed are completely conserved among several
mosquito- and tick-borne ﬂaviviruses, indicating that they are of biological importance to the virus.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The Flaviviridae family includes several arthropod-borne viruses,
which are important human pathogens, such as dengue virus,
yellow fever virus, and West Nile virus (WNV). West Nile virus is
a mosquito-transmitted virus that can cause febrile illness, severe
encephalitic disease, and death in humans and other vertebrates,
and is endemic to regions of Africa, Europe, and North America. The
positive-sense RNA genome of WNV codes for three structural
proteins (C, prM, and E) and seven non-structural proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, and NS5), which are expressed as a
single large polyprotein that is co- and post-translationally pro-
cessed into the 10 individual proteins (Chambers et al., 1990). The
structural proteins arrange in icosahedral geometry to form mature
enveloped virions and package the infectious genome, while the
non-structural proteins are required for viral RNA replication and
interact with a multitude of cellular pathways. Many viruses have
evolved multifunctional proteins to overcome limitations in the
coding capacity of their often relatively small genomes and several
examples of replication proteins that also interfere with the
immune response to infection can be found within the Flaviviridae.
For example, the Hepatitis C virus NS3 protein exhibits RNA
helicase activity required for replication, and protease activity
in conjunction with its cofactor NS4A, required for polyprotein
processing (Reed and Rice, 1998). However, protease activity also
cleaves the innate immune adaptor proteins TIR-containing,
adaptor-inducing IFN-β (TRIF), and IFN-β promoter stimulator-1
(IPS-1), which transmit signals from the pattern-recognition
receptors (PRR) Toll-like receptor 3 (TLR3), TLR4, retinoic acid-
inducible gene I (RIG-I), and melanoma-differentiation associated
gene 5 (MDA-5) (Li et al., 2005; Loo et al., 2006).
The NS5 protein is the RNA-dependent, RNA polymerase and has
been shown for several ﬂaviviruses to also inhibit signal transducer
and activator of transcription 1 (STAT1) and/or STAT2 signaling
originating from the type I interferon (IFN) receptor by different
mechanisms depending on the virus species (Ashour et al., 2009;
Laurent-Rolle et al., 2010; Lin et al., 2006, 2004; Mazzon et al.,
2009; Park et al., 2007; Werme et al., 2008). The dengue, West Nile,
and Kunjin virus NS2A, NS4A, and NS4B proteins, whose functions
in RNA replication are not well understood, are also involved in
interfering with Janus-activated kinases (JAK)-STAT signaling from
the type I IFN receptor (Evans and Seeger, 2007; Liu et al., 2006,
2005; Munoz-Jordan et al., 2005, 2003). Inhibition of these innate
immune signaling pathways decreases both type I IFN and cytokine
production, and type I IFN responses in infected cells, which
normally lead to interferon-stimulated gene (ISG) expression. The
collective function of these non-structural proteins blunts the
establishment of an antiviral state in the host cell and allows for
increased virus dissemination within the host.
NS1 is a glycoprotein that is expressed intracellularly and is also
secreted from infected cells. A hydrophobic signal sequence derived
from the C-terminus of the E protein promotes NS1 translocation into
the lumen of the endoplasmic reticulum (ER) following polyprotein
translation and is subsequently cleaved by cellular signal peptidases
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(Chambers et al., 1990). Most ﬂavivirus NS1 proteins contain two N-
linked glycosylation sites and twelve conserved cysteine residues.
Viruses within the Japanese Encephalitis Serocomplex, with exception
of Japanese Encephalitis virus itself, contain three N-linked glycosyla-
tion sites. This additional glycosylation site resides at position 175 of
the WNV NS1 protein. NS1 forms heat-labile but detergent-resistant
dimers and the secreted form has also been reported to bind to naive
cells. In the case of endothelial cells, this is achieved through cell
surface interactions between NS1 and the glycosaminoglycans,
heparan sulfate and chondroitin sulfate E (Alcon-LePoder et al.,
2005; Avirutnan et al., 2007). NS1 has also been shown to bind to
and become endocytosed into other cell types such as hepatocytes
(Alcon-LePoder et al., 2005). While its function during virus replication
is not completely understood, NS1 is absolutely required for RNA
replication and plays a role in early negative-sense RNA synthesis
(Khromykh et al., 1999; Lindenbach and Rice, 1997, 1999; Westaway et
al., 1997). Recent work by Youn et al. (2012) has demonstrated a direct
protein:protein interaction between NS1 and NS4B in infected cells,
which may facilitate interactions with the replication complex. NS1
has recently been implicated in various aspects of ﬂavivirus pathogen-
esis such as binding to and promoting the degradation of complement
factors (Avirutnan et al., 2010, 2011; Chung et al., 2006a). Paradoxically,
antibodies to NS1 aid the clearance of infected cells by complement-
mediated phagocytosis and NS1-speciﬁc antibodies have been shown
to confer a protective effect when administered prior to viral challenge
(Chung et al., 2006b, 2007; Schlesinger et al., 1990).
TLR3 is an evolutionarily-conserved PRR that recognizes dsRNA,
a replication intermediate of many RNA viruses and a component of
secondary RNA structures found in viral genomes. TLR3 activation
in endosomes leads to the induction of pro-inﬂammatory cytokines
and type I IFN expression, and induces an antiviral state in cells
(Nishiya et al., 2005; Yamamoto et al., 2002). Other cytokines, such
as IL-6, are also important for the acute phase response to infection,
can induce fever, and support the growth and maturation of B cells
(Rummel et al., 2006) We have previously reported that NS1
expressed by itself in HeLa and HEK293-TLR3 cells, and in the
context of WNV infection inhibits TLR3 (Scholle and Mason, 2005;
Wilson et al., 2008). Aside from the HCV protease, Pestivirus N(pro),
and dengue virus protease, which target IPS-1, interferon regulatory
factor 3 (IRF3), and stimulator of interferon genes (STING), respec-
tively, NS1 is so far the only other ﬂavivirus non-structural protein
to interfere with PRR signaling (Aguirre et al., 2012; Hilton et al.,
2006; Loo et al., 2006; Yu et al., 2012) In this study we aimed to
identify amino acids of NS1 that are required for TLR3 inhibition.
Traditional approaches, such as progressive truncation of the NS1
protein, neglect the indispensible role of NS1 in genome replication.
Due to the multifunctional nature of NS1, a screening approach
based on trans-complementation was developed to allow selection of
randomly mutagenized NS1 proteins that are (1) still able to support
viral RNA replication while being (2) defective in TLR3 inhibition. We
successfully identiﬁed two amino acid changes at positions P320 and
M333 of NS1 that restore TLR3 signaling and allow virus genome
replication and productive infection in HeLa cells, albeit to levels
below wt virus. These amino acids lie within the C-terminal half of the
NS1 protein, and each of these residues is conserved amongmosquito-
borne and tick-borne ﬂaviviruses. We determined that HeLa cells,
infected to equivalent levels with recombinant WNV containing the
individual mutations, are able to signal through TLR3 while wt WNV
infected cells are unresponsive to TLR3 stimulation. However,
decreased virus production was observed with both mutant viruses
suggesting that TLR3 inhibition and replication support might not be
completely separable functions of NS1. These ﬁndings suggest that
each of the identiﬁed amino acid residues are of biological importance




The overall goal of the mutational screen was to identify amino
acid changes in the NS1 protein that allow TLR3 signaling and viral
replication. The strategy was based on (1) the ability of ectopically
Fig. 1. Screen work-ﬂow for the identiﬁcation of mutagenized NS1 proteins that allow TLR3 signaling and support replication of a WNV NS1-deleted GFP replicon particle. A
HeLa reporter cell library expressing random NS1 mutants (HeLa–NFκB–DsRed2-pLEX-mNS1) was infected at an MOI of 1 with NS1-deleted WNV GFP replicon particles
(WNV ΔNS1 GFP VRP) for 24 h followed by pIC treatment for an additional 36 h. GFP and DsRed2 double-positive cells were sorted by Fluorescence-activated cell sorting
(FACS), individual clones expanded and the NS1 sequence of each clone was determined after conﬁrmation of the desired phenotype.
C.R. Morrison, F. Scholle / Virology 456-457 (2014) 96–107 97
expressed wt NS1 protein to rescue replication of a GFP-expressing
WNV replicon containing a lethal deletion in NS1, and (2) on the
ability of wt NS1 to inhibit TLR3 signaling. Fig. 1 outlines the
overall strategy. To successfully perform the screen, ﬁrst a GFP
expressing WNV replicon with a lethal deletion in NS1 was created
(WNV ΔNS1 GFP rep) and packaged into virus replicon particles
(WNV ΔNS1 GFP VRPs). Based on previous studies describing
trans-complementation of NS1, this replicon would only be able to
replicate and express GFP in the presence of wt NS1 or an NS1
variant that is able to complement the defect (Lindenbach and
Rice, 1997). A library of randomly mutagenized NS1 was estab-
lished in a recombinant lentivirus background to allow expression
in a reporter cell line, in which red ﬂuorescent protein DsRed2 is
expressed under control of an NFκB-responsive promoter. DsRed2
is only induced by pIC stimulation in cells that express NS1
proteins defective for TLR3 inhibition. During the actual screen,
reporter cells expressing mutagenized NS1 were infected with
WNV ΔNS1 GFP VRPs and subsequently treated with pIC. The
presence of GFP and DsRed2 double-positive cells indicates NS1
proteins of the desired phenotype.
Creation of an NFκB-dependent red ﬂuorescent protein reporter cell
line (HeLa–NFκB–DsRed2)
A reporter construct using the canonical NFκB response ele-
ment and a synthetic ELAM promoter, controlling expression of
DsRed2 was assembled and a stable HeLa reporter cell pool (HeLa–
NFκB–DsRed2) was established. Background ﬂuorescence was
very low and inducible expression of DsRed2 was conﬁrmed by
ﬂuorescence microscopy 36 h post-treatment with pIC (data not
shown). We have previously shown that pIC, when added to the
culture medium, will signal through TLR3 alone (Wilson et al.,
2008). To create a system for ectopic expression of NS1, WNV NS1
cDNA, including a 6X His epitope tag, was cloned into the pLEX
lentivirus vector and recombinant lentiviruses (pLEX-NS1) were
produced according to standard procedures. An empty vector
control lentivirus was used as a negative control (pLEX-MCS).
Stable cell lines were created after transduction of either HeLa–
NFκB–DsRed2 cells or standard HeLa cells with either pLEX-NS1 or
pLEX-MCS followed by antibiotic selection. HeLa–NFκB–DsRed2-
pLEX-MCS and HeLa–NFκB–DsRed2-pLEX-NS1 cells were treated
with pIC for 36 h and DsRed2 expression was analyzed by ﬂow
cytometry. Approximately 40% of pIC treated NFκB–DsRed2-pLEX-
MCS cells expressed DsRed2 after 36 h (Fig. 2A). In agreement with
our previously-published work, the number of DsRed2 positive
cells was decreased by approximately 80% in wild type NS1-
expressing cells after pIC stimulation (Fig. 2A) (Scholle and
Mason, 2005; Wilson et al., 2008). These results conﬁrm that
TLR3 signaling in this cell line results in DsRed2 expression and
that wt NS1 can inhibit this process.
Trans-complementation of an NS1-deleted replicon
A 138nt lethal in-frame deletion within the NS1 coding
sequence of a GFP-expressing WNV replicon was introduced to
create a replicon (WNV ΔNS1 GFP rep) whose replication was
dependent on trans-expressed functional NS1. in vitro transcribed
RNA of WNV ΔNS1 GFP rep was replication defective when
transfected into naïve HeLa cells or HeLa-pLEX-MCS cells. In
contrast, GFP expression from transfected WNV ΔNS1 GFP rep
RNA was readily observed in HeLa pLEX-NS1 or HeLa cells expres-
sing NS1 from a CMV promoter (Wilson et al., 2008). GFP positive
cells were visible at 24 h post transfection and GFP expression
persisted over another 24 h period, conﬁrming that trans-
expressed wt NS1 was able to sustain WNV ΔNS1 GFP rep
replication (Supplemental Fig. S1).
To facilitate delivery of WNV ΔNS1 GFP rep RNA to reporter
cells, VRPs were produced. A BHK packaging cell line (BHK-Pack
NS1) was used in which the WNV C, prM, E, and NS1 proteins are
expressed from a Venezuelan equine encephalitis (VEE) replicon.
HeLa–NFκB–DsRed2-pLEX-MCS and HeLa–NFκB–DsRed2-pLEX-
NS1 cells were infected with WNV ΔNS1 GFP VRPs for 24 h. Only
NS1-expressing cells but not vector control cells, supported
replication as evidenced by GFP detection by ﬂow cytometry
(Fig. 2B) and immunoﬂuorescence (data not shown). Taken
together these results demonstrate that the individual reagents
and cell lines necessary for the screen functioned as designed.
NS1 mutagenesis
To produce a library of mutagenized NS1 (mNS1), the coding
sequence of NS1, as well as the upstream E signal sequence, were
randomly mutated in the pLEX vector using an error-prone PCR
approach. Mutagenesis of the E signal sequence was included to
address the possibility that signal sequence or signalase cleavage
site mutants might alter TLR3 inhibition by the NS1 protein.
Reaction conditions were chosen with the objective to introduce
1 or 2nt changes per NS1 copy. Ten independent bacterial clones
were sequenced to verify the mutation frequency and to assess
gene coverage. All clones were found to harbor at least one
nucleotide substitution located throughout the 1146nt NS1 coding
sequence (data not shown). As an initial test prior to performing
the entire screen, HeLa–NFκB–DsRed2-pLEX-mNS1 cells were
plated and either infected with WNV ΔNS1 GFP VRPs for 24 h,
or treated with pIC for 36 h. Fluorescence microscopy conﬁrmed
the presence of cells expressing NS1 that supported trans-com-
plementation as well as cells expressing NS1 that allowed TLR3
signaling (data not shown). It is important to note that WNVΔNS1
GFP VRP infection for up to 72 h did not induce NFκB activation by
itself in wt NS1-expressing cells (Supplemental Fig. S2).
Screen
To perform the screen, 2.5106 HeLa–NFκB–DsRed2-pLEX-
mNS1 cells were infected with WNV ΔNS1 GFP VRPs at an MOI
of 1. GFP ﬂuorescence in some cells was readily observable at 24 h
post-infection. The cells were subsequently stimulated with pIC
for 36 h and GFP and DsRed2 double-positive cells were isolated
by FACS. The screen was performed twice using independently
established HeLa–NFκB–DsRed2-pLEX-mNS1 cell libraries.
Approximately 3104 double-positive cells were isolated and
plated into 10 cm culture plates at low density. 134 clones survived
expansion. Phenotypes of clones were conﬁrmed by indepen-
dently monitoring DsRed2 expression following pIC stimulation
and GFP expression post-infection with WNV ΔNS1 GFP VRPs.
Ultimately, 18 clones were considered promising candidates and
the NS1 sequence was determined, which resulted in four unique
sequences (Table 1). Some sequences were present in more than
one of the clones. This can most likely be attributed to allowing
the original mutant cell library to expand prior to the sort.
Multiple independent selections of the same sequence conﬁrm
the reproducibility of our screen.
All NS1 sequences identiﬁed by the screen had two nucleotide
substitutions resulting in point mutations. Notably, no clones were
identiﬁed that encoded truncated or elongated forms of NS1, and
no changes were found in the E signal sequence. Identiﬁed amino
acid changes were reconstituted both individually, as well as in
combination in the pLEX-NS1 sequence, and were packaged into
recombinant lentiviruses. These lentivirus particles were used to
transduce a HeLa cell line, which contained a luciferase reporter
gene driven by the NFκB responsive ELAM promoter, HeLa–NFκB-
luc. To verify that the amino acid changes did not adversely affect
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Fig. 2. Validation of the tools employed by the screen. (A) HeLa–NFκB–DsRed2 cells stably transduced with either pLEX-NS1 or pLEX-MCS (vector control) lentivirus were
treated with pIC for 36 h or left untreated and DsRed2 expression was determined by ﬂow cytometry. (B) HeLa–NFκB–DsRed2 cells stably transduced with either pLEX-NS1
or pLEX-MCS (vector control) lentivirus were either infected for 24 h with WNV ΔNS1 GFP VRPs or mock infected. GFP expression was determined by ﬂow cytometry. Data
are representative of three independent experiments.
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protein expression, immunoblot analysis was performed in the
stably expressing cell lines prior to WNV ΔNS1 GFP VRP infection
(Fig. 3A). All NS1 mutants, as well as wt NS1 were expressed to
similar levels. The mutation at position 177 eliminates one of the
NS1 N-linked glycosylation sites at position 175 (see below)
explaining the increased mobility of NS1 proteins containing this
substitution. In the immunoblot shown in Fig. 3A we had to resort
to using an anti-His antibody against the epitope tag, since all
NS1-speciﬁc antibodies available to us did not detect the mutant
proteins efﬁciently. This was also true for immunoﬂuorescence
and ﬂow cytometry.
Ability of NS1 proteins encoding amino acid changes
to trans-complement
HeLa cell lines expressing NS1 with individual or double amino
acid changes were infected at low MOI of 0.15 with WNV ΔNS1
GFP VRPs for 36 h and GFP expression was investigated by
ﬂuorescence microscopy and by ﬂow cytometry to determine the
mean ﬂuorescent intensity (MFI) of the GFP signal (Fig. 3B and C).
Trans-complementation by NS1 proteins encoding the indivi-
dual T177N, N191I, E238V, or G295R changes was similar to wt
NS1. In contrast, cells expressing NS1 proteins with the individual
changes N255D, T317I, P320S, and M333V trans-complemented to
reduced levels compared to wt NS1. All cell lines expressing
double amino acid changes in the NS1 protein (T177N/G295R,
N191I/P320S, E238V/N255D, and T317I/M333V) also had signiﬁ-
cantly reduced GFP MFI following infection (Fig. 3B and C).
In summary, NS1 protein encoding changes T177N, N191I,
E238V, and G295R trans-complemented at levels comparable to
wt NS1. The remaining identiﬁed amino acid changes in NS1
resulted in less efﬁcient trans-complementation than with wt
NS1 protein. Interestingly, the originally identiﬁed double mutants
showed a greater reduction in trans-complementation ability than
the individual single amino acid substitutions.
TLR3 inhibition by NS1 proteins encoding amino acid substitutions
TLR3 signaling in HeLa–NFκB-luc cells expressing NS1 proteins
encoding amino acid substitutions was measured by IL-6 ELISA
(Fig. 4A) and NFκB activation by luciferase reporter assay (Fig. 4B)
following pIC stimulation. TLR3 signaling was severely inhibited in
cells expressing wt NS1, as well as NS1 encoding the T177N, N191I, or
E238V substitutions. While the IL-6 response to pIC stimulation was
weak in cells expressing G295R NS1 protein, they responded similar to
non NS1-expressing cells when NFκB activation was assessed. TLR3
signaling was completely restored in N255D and T317I NS1-expressing
cells, and signiﬁcantly restored in cells expressing P320S and M333V
NS1 proteins (Fig. 4A and B). Complete responsiveness to pIC was also
observed in cells expressing each of the NS1 double amino acid
substitutions, with the exception of T177N/G295R NS1.
The combined results of trans-complementation and TLR3 signal-
ing in cells expressing NS1 variants lead us to conclude that NS1
T177N, N191I, and E238V behave like wt NS1 for the functions we
assessed. NS1 G295R and T177N/G295R also functioned most similar
to wt NS1, but did allow slightly higher levels of NFκB activation and
IL-6 secretion, respectively. Several other substitutions identiﬁed by
the screen completely restored TLR3 signaling, but signiﬁcantly
impaired trans-complementation (N255D, T317I, N191I/P320S,
E238V/N255D, T317I/M333V). Of the remaining NS1 changes identi-
ﬁed by the screen, P320S and M333V NS1 supported intermediate
levels of trans-complementation and allowed signiﬁcant TLR3 signal-
ing (Figs. 3 and 4). These substitutions were selected for further study
in the context of the full length WNV genome.
Identiﬁcation of highly-conserved amino acid residues
at the C-terminal half of the NS1 protein
The amino acid sequences of 10 mosquito-borne and 6 tick-
borne ﬂavivirus NS1 proteins were aligned using ClustalW. The
Table 1
NS1 nucleotide and amino acid substitutions identiﬁed in screen.
Nucleotide Amino acid
Clone aPosition Change bPosition Change
1 530 C:A 177 T:N
883 G:A 295 G:R
2 72 A:T 191 N:I
958 C:T 320 P:S
3 713 A:T 238 E:V
763 A:G 255 N:D
4 950 C:T 317 T:I
997 A:G 333 M:V
a NS1 is 1046 nucleotides in length.
b NS1 is 352 amino acids in length.
Fig. 3. Efﬁciency of identiﬁed mutant NS1 proteins to trans-complement WNV
ΔNS1 GFP VRPs. (A) HeLa–NFκB-luc reporter cells were transduced with lentivirus
expressing either wt NS1, MCS, or single or double NS1 amino acid changes and
selected for puromycin resistance. 5 mg of whole cell lysate from each cell line were
probed for NS1 expression by immunoblot and normalized to β-actin expression.
(B) HeLa–NFκB-luc reporter cells stably transduced with lentivirus expressing
either wt NS1, MCS, or single or double NS1 amino acid substitutions were infected
at an MOI of 0.15 for 36 h with WNV ΔNS1 GFP VRPs or mock infected. Expression
of GFP was quantiﬁed by ﬂow cytometry by determining the mean ﬂuorescent
intensity (MFI). The background MFI of identically infected MCS cells was
subtracted from the MFI determined for other infected cells. Data are the average
of two independent experiments and error bars represent standard deviation from
the mean. (C) GFP expression due to trans-complementation by wild type and NS1
proteins with coding changes was monitored by ﬂuorescence microscopy.
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mutations identiﬁed by the screen with the most desired pheno-
type lie in the C-terminal half of the NS1 protein. Residues P320
and M333 are evolutionarily conserved among all ﬂavivirus NS1
proteins that were aligned, suggesting that these positions are of
biological importance to the viruses (Fig. 5). In contrast, T177N and
N191I amino acid residue changes had no effect on the functions
we assessed, and were found to have variable residues at those
positions (data not shown). E238, while not conserved among all
ﬂaviviruses, was completely conserved among mosquito-borne
ﬂaviviruses, however, a change at that residue retained a wild
type NS1 phenotype. Residues N255 and G295 are completely
conserved. A change at position 255 to aspartic acid resulted in a
loss of function phenotype, while the change at position 295 to an
arginine resulted in a predominantly wild type phenotype. Resi-
due T317 was only partially conserved among mosquito-borne
ﬂaviviruses and a change to isoleucine negatively impacted both
NS1 functions we assessed.
Not surprisingly, the NS1 proteins of the examined ﬂaviviruses
share signiﬁcant homology as determined by Shannon entropy
calculations (average H value¼1.24). Overall, the C-terminal half of
the protein was slightly more conserved than the N-terminal half
(average H value N-terminal half¼1.36, C-terminal half¼1.11).
Taken together, residues 320 and 333 are evolutionarily conserved,
and substitutions at these positions showed the most promising
phenotype in our screen to separate TLR3 inhibition from NS1's
function in RNA replication.
NS1 mutations affect WNV growth in vitro
During the screen, NS1 protein was ectopically expressed,
independent of other viral proteins. During RNA replication, non-
structural proteins need to interact with each other properly to
form a functioning replication complex. To investigate the effects
of the identiﬁed coding changes on genome replication and virus
production, the P320S and M333V amino acid substitutions were
introduced individually into a WNV infectious clone and recombi-
nant mutant viruses were produced in BHK cells. Multistep growth
curves were performed on HeLa cells for up to 96 h post-infection.
Both WNV mutants were attenuated in HeLa cells with virus titers
being lower than wild type virus at all time points examined
(Fig. 6A). Differences in replication kinetics were also observed
between the two mutant viruses with WNV NS1 M333V being
signiﬁcantly more attenuated in HeLa cells than WNV NS1 P320S.
Effect of WNV NS1 mutants on TLR3 signaling in HeLa cells
TLR3 signaling was measured in WNV infected cells in response
to pIC. Previous studies with HeLa cells demonstrated that IL-6
secretion in response to pIC treatment is TLR3-dependent and can
be abolished in cells transfected with TLR3-speciﬁc siRNA (Wilson
et al., 2008). HeLa cells were infected for 20 h with WNV followed
by 8 h of pIC treatment. Wild type WNV robustly inhibited IL-6
secretion following pIC treatment compared to mock infected cells
(Fig. 6B). Cells infected with WNV NS1 P320S efﬁciently responded
to pIC treatment with IL-6 secretion similar to mock infected cells.
WNV NS1 M333V infected cells showed an intermediate pheno-
type and responded signiﬁcantly to pIC stimulation compared to
wt WNV but still signiﬁcantly inhibited TLR3 compared to mock
infected cells. Given that each mutant virus displayed growth
attenuation in HeLa cells, the percentage of infected cells in each
case was determined by ﬂow cytometry. All viruses were equally
able to infect HeLa cells as determined by expression of the E
protein (Fig. 6C) and the MFI was similar in all three cases,
suggesting that differences in protein expression alone do not
account for the observed differences in TLR3 inhibition. Due to the
issues of inefﬁcient recognition of the mutant NS1 proteins by
anti-NS1 antibodies and the lack of an epitope tag in the context of
the full-length virus genome, we were not able to directly compare
expression levels of NS1 proteins in these experiments.
Discussion
We have previously demonstrated that the WNV NS1 glyco-
protein inhibits TLR3 signaling (Scholle and Mason, 2005; Wilson
et al., 2008). In this study, we developed a FACS-based screen to
identify randomly-generated amino acid changes within the NS1
protein that restore TLR3 signaling, while allowing the protein to
still function in virus genome replication. Initially, the components
of the screen were successfully validated and mutagenic coverage
was assessed. The mutagenesis was unbiased and nucleotide
changes were found throughout the coding sequence of NS1.
Following two screens using independently-established mutant
Fig. 4. Efﬁciency of TLR3 signaling in cells expressing mutant NS1 proteins. HeLa–
NFκB-luc reporter cells stably transduced with lentivirus expressing either wt NS1,
MCS, or single or double NS1 amino acid changes were treated with 20 mg/ml pIC
for 8 h or left untreated. (A) IL-6 secretion in the supernatants of cells was
determined by enzyme-linked immunosorbent assay (ELISA) and fold induction
was calculated by comparing IL-6 produced by pIC treated cells to that of untreated
cells. Data are the average of two independent experiments performed in biological
triplicate and error bars represent standard deviation from the mean. Statistical
signiﬁcance was determined by Mann–Whitney U test, where npr0.05 NS¼not
signiﬁcant. All samples were compared to wt NS1. (B) Fold NFκB induction was
determined by luciferase reporter assay. Relative light units were measured and
reported as fold induction over untreated cells. Data are the average of two
independent experiments and error bars represent standard deviation from the
mean. Statistical signiﬁcance was determined by Student's t-test, where npr0.05
NS¼not signiﬁcant. All samples were compared to wt NS1.
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NS1 libraries, we identiﬁed approximately 3104 double-positive
cells of which 134 survived clonal expansion. Of the expanded
clones, 18 displayed the desired phenotype. While cell viability
due to VRP infection alone was not negatively affected as deter-
mined by MTT assay (data not shown), the combination of VRP
infection, pIC treatment, the stress of the sorting process, and
antibiotic selection likely contributed to a decrease in clonal cell
survival. Nevertheless, the identiﬁcation of several clones with
the desired phenotype conﬁrms that our screening strategy was
successful.
Overall, four unique double amino acid changes were identi-
ﬁed: T177N/G295R, N191I/P320S, E238V/N255D, and T317I/
M333V. Analysis of the effect of individual amino acid changes
at each of the eight positions demonstrated that changes at
residues 177, 191, 238, and 295 did not affect replication in our
trans-complementation assay. These same residues also did not
seem to be involved in TLR3 inhibition. The notable exception is
the change at position 295, which allowed partial activation of
NFκB but not IL-6 secretion. The screen only monitored NFκB
activation while transcription of IL-6 involves other transcrip-
tion factors in addition to NFκB, such as AP-1, which may still be
inhibited by G295R. The T177N substitution was initially of
particular interest because it ablates N-linked glycosylation at
position 175, and numerous other studies have described a role
for NS1 glycosylation in virulence and pathogenesis of several
ﬂaviviruses (Muylaert et al., 1996; Pryor and Wright, 1993, 1994;
Tajima, Takasaki, and Kurane, 2008; Whiteman et al., 2010,
2011). However, T177N NS1 behaved like wild type protein for
trans-complementation and TLR3 inhibition, suggesting that at
least this particular glycosylation site is not critical for TLR3
inhibition and/or RNA replication.
The changes at residues 255 and 317 conferred the opposite
phenotype, negatively impacting trans-complementation of
viral RNA synthesis while allowing TLR3 signaling to occur.
These results could either be interpreted that residues 255 and
317 are involved in TLR3 inhibition and that simultaneously, the
amino acid substitutions have a negative effect on replication, or
that changing these residues render NS1 simply non-functional.
In addition to these single amino acid substitutions, the com-
bined residue changes also negatively impacted NS1 protein
functions, demonstrating the sensitivity of the NS1 protein to
mutation. The ability of our screen to identify these attenuated
double-amino acid substitution clones indicates that our FACS-
based strategy was highly sensitive. Ultimately the P320S and
M333V single substitutions were shown to be the minimal
changes necessary to allow TLR3 signal transduction, while still
permitting the trans-complementation and rescue of an NS1-
deleted VRP. It is important to note, however, that TLR3 signal-
ing was not fully restored and that trans-complementation was
inferior to wt NS1. These ﬁndings indicate that there is most
likely a reciprocal relationship between restoration of TLR3
signal transduction and maintenance of replication competency.
Thus, complete separation of the two functions might not be
feasible, with a possible explanation being, that the region
responsible for TLR3 inhibition is also involved in RNA
replication.
Fig. 5. Shannon entropy (H) and multiple protein alignment of the NS1 proteins of several mosquito- and tick-borne ﬂaviviruses. The amino acid sequences of 10 mosquito-
borne and 6 tick-borne ﬂaviviruses were aligned with ClustalW using the Blosum scoring matrix. The multiple-alignment ﬁle was displayed with BOXshade 3.21 where
black-shading represents identical residues and gray-shading represents conserved substitutions. Shannon entropy analysis of the multiple protein alignment was performed
by the Protein Variability Server (PVS) at the Complutense University of Madrid, and the data generated was displayed in MS Excel. Hr1 are considered highly conserved
residues. Mosquito-borne ﬂaviviruses are represented in bolded font and tick-borne ﬂaviviruses in italics.
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Interestingly, a previous clustered charged-amino-acid-to-ala-
nine mutagenesis study of the yellow fever virus NS1 protein
identiﬁed mutations lethal to virus replication only in the N-
terminal half of the protein, while the majority of tolerated
mutations mapped to the C-terminal half (Muylaert et al., 1997).
Consistent with these results, none of the amino acid changes we
identiﬁed in the screen fall into the N-terminal half of the NS1
sequence. One possible explanation for these ﬁndings is that the
N-terminal half of the protein is critically involved in replication
and highly sensitive to mutagenesis. Further, the C-terminal half of
the protein also contributes to replication, but in addition, func-
tions in TLR3 inhibition and is more tolerant to mutagenesis. The
idea that non-structural proteins may contain overlapping func-
tional domains is not new among the ﬂaviviruses. The Langat NS5
protein is the RdRp and also functions to inhibit JAK/STAT signaling
originating from the type I IFN receptor (Park et al., 2007). Fine
mapping of the Langat NS5 inhibitory domains indicated that
regions and residues necessary for IFN inhibition are located
within the highly conserved RdRp domain.
In our case, ClustalW alignment of the C-terminal half of 10
mosquito-borne and 6 tick-borne ﬂavivirus NS1 proteins revealed
high sequence similarity in this region of the protein, and residues
P320 and M333 are fully conserved, suggesting that their functions
in both replication and TLR3 inhibition could be evolutionarily and
biologically important.
In a recent study, Baronti et al. (2010), were unable to ﬁnd a role for
the NS1 proteins of several ﬂaviviruses in inhibiting TLR3 signaling. In
that study, the investigators relied on the induction of IFN-β tran-
scripts as a primary readout for TLR3 signaling within HEK293-TLR3
cells and in HeLa cells. We determined previously that HeLa cells fail to
produce signiﬁcant levels of IFN-β transcript and protein following pIC
stimulation alone, which may explain these conﬂicting results (Wilson
et al., 2008). Further, the authors of that study had to resort to
overexpressing both TLR3 and IRF3 in the HeLa cell lines in order to
induce IFN-β transcription following pIC stimulation. As the mechan-
ism of NS1-mediated TLR3 inhibition is currently unknown, IRF3
overexpression in these cells may have bypassed the step(s) in the
TLR3 signaling pathway at which NS1 blocks signal transduction. Our
current results conﬁrm not only that wt NS1 inhibits TLR3 signaling as
previously observed using multiple read-outs, but also that NS1 can be
mutated at speciﬁc residues to restore NFκB activation and IL-6
transcription and secretion, in response to TLR3 stimulation, while
other mutations yield a wt NS1 phenotype.
In addition to ectopic expression studies of the NS1 proteins,
mutant WNV growth and TLR3 signaling studies were undertaken in
HeLa cells. Both P320S and M333V NS1 WNV were attenuated for
growth in HeLa cells and allowed TLR3 signaling in response to pIC.
These ﬁndings demonstrate that the identiﬁed mutations in the
context of a WNV infectious clone faithfully recapitulated the pheno-
types observed during overexpression of the NS1 protein alone. This is
an important ﬁnding, as a previous mutagenesis study with the IFN
antagonistic WNV NS4B protein was unable to reproduce phenotypes
observed with mutant replicons/over expressed protein in the context
of an infectious WNV mutant (Evans and Seeger, 2007).
Ultimately, interference with TLR3 signaling is expected to alter
the host response to beneﬁt the virus. Future studies will inves-
tigate pathogenesis and immune responses to our mutant viruses.
P320S NS1 WNV replicated more efﬁciently and allowed increased
TLR3 signaling to occur compared with M333V NS1 WNV, and may
represent an important tool to investigate the role of the TLR3
inhibitory function of NS1 during WNV infection. Additionally, the
identiﬁcation of P320 as a residue important for TLR3 inhibition is
likely to prove valuable for determining the mechanism by which
NS1 antagonizes TLR3 signal transduction.
Materials and methods
Construction of VSV-G psudotyped lentivirus particles expressing NS1
(pLEX-NS1)
Full length WNV NS1, including the last 30 amino acids of the E
protein and a C-terminal 6X Histidine tag was cloned into the
pLEX vector (ThermoScientiﬁc/OpenBiosystems) and pLEX-NS1
was packaged into VSV-G pseudotyped, replication-defective,
lentivirus particles through co-transfection of HEK 293T cells with
Fig. 6. Replication kinetics and TLR3 inhibition of mutant WNV expressing the
identiﬁed amino acid residue changes in the NS1 protein. (A) HeLa cells were
infected at an MOI of 0.01 with each WNV NS1 mutant and virus containing
supernatants were collected every 24 h for 96 h. Infectious virus was titered on
Vero cells by immunofocus assay. Growth curves were performed in biological
triplicate and data are representative of two independent experiments. Error bars
represent standard deviation from the mean. Statistical signiﬁcance was deter-
mined by Student's t-test, where npr0.05. (B) HeLa cells were infected at an MOI of
5 with each WNV NS1 mutant for 1 h, washed with PBS, replaced with fresh
medium, and allowed to incubate for 20 h. Medium was removed and replaced
with medium with or without pIC (20 mg/ml) for 8 h. Cell culture supernatants
were collected and IL-6 concentrations were determined by ELISA as pg of IL-6/ml.
Data are representative of three independent experiments and error bars represent
standard deviation from the mean. Statistical signiﬁcance was determined by
Student's t-test, where npr0.05 and NS¼not signiﬁcant. All samples were
compared to mock infected cells treated with pIC. (C) HeLa cells infected with
identical amounts of wt and mutant viruses were ﬁxed and permeabilized 28 h
post-infection and infected cells were identiﬁed by ﬂow cytometry using an E
protein-speciﬁc primary monoclonal antibody and were detected with a secondary
Alex Fluor 488 antibody. Grey ﬁlled histograms represent uninfected control cells
and black open histograms represent E protein in WNV infected cell. Data are
representative of three independent experiments.
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vector, packaging (pREV and pMDLg), and envelope (pVSV-G)
plasmids. Empty vector (pLEX-MCS) was packaged identically.
Lentivirus-containing supernatants were harvested and clariﬁed
40 h post-transfection, and stored at 80 1C until further use.
Construction of VSV-G psudotyped lentivirus particles expressing
mutant NS1 (pLEX-mNS1)
NS1 mutants (mNS1) were generated by error-prone PCR of the
pLEX-NS1 plasmid using a Gene MorphII EZ clone kit (Agilent
Technology/Stratagene), according to the manufacturer's instruc-
tions, with the following primers; mutFw 50 AAT TCG CCC TTG AAT
CGG ATC C 30 and mutRev 50 GGT GAT GGT GAT GAT GAC CGG T 30.
The input amount of template DNA was selected to achieve a
mutation frequency between 1 nucleotide (nt) and 2nt change(s)/
kilobase(kb). The E signal sequence and NS1 are 1146nt in length.
Total transformed bacteria were expanded in 250 ml of 2X YT
broth (Fisher) containing 100 mg/ml ampicillin (Sigma), plasmid
DNA was puriﬁed using a Maxi prep kit (Qiagen), and packaged as
lentivirus particles (pLEX-mNS1) as described previously.
Construction of HeLa NFκB-ELAM DsRed2 reporter cell line
(HeLa–NFκB–DsRed2)
The CMV promoter of the pDsRed2-C1 plasmid (Clontech) was
removed by digestion with PciI and AgeI restriction endonucleases.
The 5X NFκB endothelial-leukocyte adhesion molecule-1 (ELAM)
promoter of the pNiFtY-SEAP plasmid (Invivogen) was PCR ampli-
ﬁed with the following primers; NFκB5XELAM Fw (PciI) 50 ATT
ATA CAT GTA TCG CTG AAT TCT GGG GAC T 30 and NFκB5XELAM
Rev (AgeI) 50 ATT ATA CCG GTG GCT CTG TCT CAG GTC AGT A 30, to
produce a 278 base pair (bp) amplicon, that was subsequently
digested with PciI and AgeI enzymes, and ligated into the
pDsRed2-C1 plasmid (NFκB–DsRed2). HeLa cells were transfected
(Mirus IT LT-1) with 500 ng of NFκB–DsRed2 plasmid. A polyclonal
cell population (HeLa–NFκB–DsRed2) was selected with 500 mg/ml
G418 (Lonza) and response to treatment with 20 mg/ml Polyino-
sinic:polycytidylic acid (pIC) (Calbiochem) was conﬁrmed by
detection of DsRed2 with ﬂuorescence microscopy and ﬂow
cytometry 36 h later.
Construction of HeLa NFκB-ELAM luciferase reporter cell line
(HeLa–NFκB-luc)
The NFκB 5X ELAM promoter of the pNiFty-SEAP plasmid
(Invivogen) was PCR ampliﬁed using the following primers:
NFκB5XELAM Fw (KpnI): 50 ATT ATG GTA CCA TCG CTG AAT TCT
GGG GAC T 30 and NFκB5XELAM Rev (HindIII): 50 ATT ATA AGC
TTG GCT CTG TCT CAG GTC AGT A 30. The amplicon was digested
with KpnI and HindIII restriction endonucleases and ligated into
KpnI and HindIII sites of the pGL4.15 vector (Promega) upstream of
the luciferase reporter gene. HeLa cells were transfected (Mirus, IT
LT-1) with 500 ng of the reporter construct and a stable, polyclonal
cell line was selected by 400 μg/ml hygromycin (Cellgro). Respon-
siveness of the HeLa–NFκB-luc cell line was conﬁrmed by lucifer-
ase assay following 8 h treatment with 20 mg/ml pIC.
VSV-G pseudotyped lentivirus particle transduction and titration
For creation of a random mutant NS1 reporter cell library (HeLa–
NFκB–DsRed2-pLEX-mNS1), HeLa–NFκB–DsRed2 cells were trans-
duced at an MOI of 0.02 with pLEX-mNS1 particles to ensure fewer
than 1 integration event per cell. HeLa–NFκB–DsRed2 cells were
plated in 6-well plates and overlaid with 2ml of 1þ1þ1 DMEM
(1X DMEM (CellGro) with 1% Pen/Strep (CellGro), 1% HEPES buffer
(CellGro), 1% FBS (Gemini)), containing 8 mg/ml polybrene (Sigma), and
lentivirus-containing supernatant. Medium was changed 24 h post-
transduction to 1X DMEM with 10% FBS and cells were placed under
puromycin selection (2 mg/ml) (Gemini) 48 h later. HeLa–NFκB–
DsRed2 cells or standard HeLa cells were also transduced with either
pLEX-NS1 or pLEX-MCS lentivirus particles to serve as controls.
Lentivirus titers were determined by counting crystal violet-
stained, puromycin-resistant HeLa cell colonies following trans-
duction with serial dilutions of lentivirus-containing supernatants.
Construction, packaging, and titration of ΔNS1 GFP VRPs
A GFP-expressing WNV replicon (WNV GFP rep) (a gift from
P.W. Mason), based on WNR C-NS1-5 with an insertion of GFP and
the FMDV 2A autoprotease coding sequences between the capsid
and the NS1 signal sequence (Bourne et al., 2007) served as a
backbone for introduction of a lethal 138 bp (46 amino acid) in-
frame deletion in NS1. Initially, the WNV GFP rep plasmid served
as template for PCR to amplify the ﬁnal 60 bp of NS1, (incorporat-
ing a BstEII restriction site at the 50 end the amplicon) along with
full-length NS2A (which contains a unique XmaI restriction site),
using the following primers; delNS1 BstEII Fw 50 ACG TGG TCA
CCA TGG AGA TCA GAC CAC AGA GAC ATG 30 and delNS1 NS2A Rev
50 TCT GGC ACA TCG TAT GGG TAG CGT TTA CGG TTG GGA TCA CAT
GC 30. The 790 bp amplicon was subsequently digested with BstEII
and XmaI restriction endonucleases and ligated into the BstEII and
XmaI restriction sites of WNV GFP rep DNA.
WNV ΔNS1 GFP rep DNA was linearized by XbaI digestion
followed by phenol:chloroform extraction and RNA was transcribed
in vitro using a transcription reaction kit (Ambion) incorporating a
m7GpppAmpN2 cap analogue (NEB). BHK packaging cells expressing
WNV C, PrM, E, and NS1 (BHK-Pack NS1, a gift from P.W. Mason) from
a non-cytopathic Venezuelan equine encephalitis alphavirus (VEE)
replicon, were electroporated with WNV ΔNS1 GFP rep RNA. WNV
ΔNS1 GFP VRP containing supernatants were collected every 24 h in
1þ1þ1 MEM medium, clariﬁed, and stored at 80 1C until further
use. For titration, wt NS1 expressing HeLa cells were infected for 24 h
with WNV ΔNS1 GFP VRPs and GFP positive cells were quantiﬁed by
ﬂow cytometry.
Screen conditions
2.5106 HeLa–NFκB–DsRed2-pLEX-mNS1 cells were plated in
a T-75 ﬂask and allowed to grow for 24 h. Medium was removed
and cells were infected at an MOI of 1 with WNV ΔNS1 GFP VRPs
in 1þ1þ1 DMEM for 24 h. Infected cells were treated with 20 mg/
ml pIC in 1þ1þ1 DMEM for an additional 36 h. Cells were
removed from the ﬂask by trypsinization, washed, and double-
positive cells (GFP and DsRed2) were sorted by Fluorescence-
activated Cell Sorting (FACS, Cytomation). Sorted cells were plated
at low density in 10 cm cell culture dishes and maintained in
medium containing 2 mg/ml puromycin and 500 mg/ml G418.
Surviving colonies were isolated and expanded. The phenotypes
of the resulting clonal cell lines were conﬁrmed by infecting with
an MOI of 1 with WNV ΔNS1 GFP VRPs or treating with 20 mg/ml
pIC and monitoring GFP or DsRed2 expression by ﬂuorescence
microscopy.
Genomic DNA was puriﬁed from the clonal cell lines using a
QIAamp DNA mini kit (Qiagen). Integrated mNS1 was PCR ampli-
ﬁed using the following primers; CMVIEFw 50 ACT TAC GGT AAA
TGG CCC GC 30, IRESRev and 50 AAA GGA AAA CCA CGT CCC CG 30
and puriﬁed amplicons were sequenced.
Site-directed mutagenesis
NS1 point mutations identiﬁed in the clonal cell lines were
reconstituted individually or as pairs in the pLEX-NS1 vector, using
C.R. Morrison, F. Scholle / Virology 456-457 (2014) 96–107104
the PCR based Quick Change II XL kit (Agilent Technologies/Strata-
gene). Site-directed primer pairs were designed using the Quick
Change primer design software. Each primer pair was designed to
incorporate a single nucleotide change resulting in a single point
mutation. Fidelity of the mutagenesis was conﬁrmed by standard DNA
sequencing. Reconstituted mutants were packaged as lentivirus parti-
cles and used to produce stable, polyclonal mutant NS1-expressing
HeLa–NFκB-luc cells as described previously.
NFκB-luciferase reporter assays
HeLa–NFκB-luc cells expressing the reconstituted NS1 mutants
were plated at 4104 cells total per well in a 48-well plate.
Triplicate wells of each cell line were either treated with 20 mg/ml
pIC for 8 h or left untreated. Supernatants were stored at 80 1C
for IL-6 ELISA (described below). Cells were washed once with PBS
and lysed for 30 min in lysis buffer (0.3 M NaCl, 0.05 M TrisHCL,
0.1%TritonX-100) on ice. Cell debris was removed by centrifuga-
tion and supernatants were incubated with luciferase reagent
(Promega) and light emission was measured on a luminometer
(Berthold) as Relative Light Units/ml (RLU/ml). The RLU/ml of each
sample was then normalized to total protein in the whole cell
lysate (RLU/ml/mg protein), as determined by a commercial protein
assay kit (BioRad). Data were expressed as fold NFκB induction
over unstimulated cells.
ELISA
Cell culture supernatants were collected as described and
assayed for human IL-6 using a commercial ELISA kit (Ebioscience).
IL-6 secretion was then calculated as fold secretion over unstimu-
lated cells or as pg/ml where indicated.
Immunoblotting
Whole cell lysates were prepared in lysis buffer as described.
Equivalent amounts of protein (5 mg) were mixed with LDS buffer
(Invitrogen) containing 2.5 mM DTT, heated at 90 1C for 5 min, and
loaded into 4–12% Bis–Tris NuPAGE gels (Invitrogen). Proteins
were electrophoretically separated, transferred to a PVDF mem-
brane (Immobilon Millipore), and probed with one of the follow-
ing primary antibodies: 1:4000 dilution of mouse anti-tetra-His
monoclonal antibody (34679; Qiagen) to detect NS1 or 1:10,000
dilution of mouse anti-β-actin monoclonal antibody (A1978;
Sigma). Bound antibodies were detected with a 1:2000 dilution
of horseradish peroxidase-conjugated goat anti-mouse IgG (HþL)
secondary antibody (474–1806; KPL and an enhanced chemilumi-
nescence detection system (Santa Cruz Biotechnology).
Flow cytometry
Detection of DsRed2 and GFP
Following the indicated treatments, HeLa–NFκB–DsRed2-pLEX-
NS1 or HeLa–NFκB–DsRed2-pLEX-MCS cells were trypsinized,
resuspended in 1X DMEM medium with 10% FBS, washed with
PBS, and 10,000 events per treatment group were recorded on a
BD FACS Calibur ﬂow cytometer using CellQuest Pro (BD) software.
Data were analyzed and displayed with WinMDI 2.8 software (The
Scripps Institute).
Detection of WNV-infected cells
HeLa cells were infected with WNV or mutant WNV using the
indicated conditions, trypsinized, resuspended in 1X DMEM med-
ium with 10% FBS, and washed once with ﬂow staining buffer (1X
PBS, 1% BSA, 1% Sodium Azide). All other steps were performed in
the dark on ice. Cells were ﬁxed and permeabilized for 20 min
with cytoﬁx/cytoperm solution (BD), washed, and incubated
with a mouse anti-dengue virus E protein monoclonal antibody
(D14G2) in cytoﬁx/cytoperm wash buffer. Following several
washes, cells were incubated with secondary goat anti-mouse
IgG (HþL) Alexa Fluor 488-conjugated antibody (Invitrogen). 5000
events per treatment group were recorded on an AccuriC6 ﬂow
cytometer using CFlow software (BD Accuri) and data were
analyzed and displayed with FlowJo version 10 (Tree Star).
Multiple protein alignment and Shannon entropy
The amino acid sequences of 10 mosquito-borne and 6 tick-
borne ﬂavivirus NS1 proteins were aligned using ClustalW. The
Blosum scoring matrix was employed with an opening gap penalty
of 10 and an extending gap penalty of 0.05 (Larkin et al., 2007).
The alignment ﬁle was graphically displayed with BOXSHADE 3.2,
where black shading represents identical residues and grey shad-
ing represents conserved substitutions. Shannon entropy was also
calculated from the multiple protein alignment based upon the
consensus reference sequence, using the Protein Variability Server
(PVS) at the Complutense University of Madrid (Garcia-Boronat et
al., 2008).
Reconstitution of NS1 mutations into a West Nile virus infectious
clone
PCR-mediated, site-directed mutagenesis, as described earlier,
was used to clone the identiﬁed changes at NS1 amino acid
positions 320 and 333, respectively, into an infectious cDNA clone
of West Nile virus of a human 2002 isolate from Texas (Rossi et al.,
2005). Fidelity of the mutagenesis was conﬁrmed by standard DNA
sequencing of the NS1 coding sequence in the cDNA clones, using
the primer set listed below. Plasmid DNA was linearized by XbaI
digestion followed by phenol:chloroform extraction and RNA was
transcribed in vitro. Wild type and mutant WNV RNAs were
electroporated into BHK cells, and viruses were captured in the
cell culture supernatants every 24 h for 120 h post-infection. Virus
containing supernatants were clariﬁed, aliquoted, and stored at
80 1C prior to use (see below).
The NS1 coding sequence of each WNV mutant and wt WNV
was assessed following virus production in BHK cells to determine
the stability of the mutations. Virus RNA was extracted from each
passage 0 (P0) virus stock, reverse transcribed and a 1198 bp
fragment containing full-length NS1 was ampliﬁed using the
following primers: WNVmNS1SEQFw 50 TGC TCG TGA CAG GTC
CAT AGC TCT 30 and WNVmNS1SEQRev 50 CTG GGT GGC CAA GAA
CAC GAC C 30. PCR products were puriﬁed by standard salt:ethanol
precipitation and sequenced with the primers listed above.
Titration of WNV
WNV was titered on monolayers of Vero cells in 48-well plates.
Virus was allowed to attach to the cells for 1 h with rocking every
15 min, and cells were overlaid with 1X MEM/1X Tragacanth Gum
(MP Biomedicals) and allowed to incubate for 48 h. Cells were
ﬁxed with a 1:1 ratio of acetone and methanol. The ﬁxed cells
were blocked with 1% Normal Horse Serum (NHS) (Gemini
Bioproducts) in PBS (1%NHS/PBS). E protein in infected cells was
detected with the D14G2 monoclonal antibody, and horseradish
peroxidase-conjugated goat anti-mouse IgG (HþL) Immunofoci
were visualized using a colorimetric HRP detection kit according
to the manufacturer's instructions (Vector Labs). Virus titer was
expressed as focus forming units/ml (FFU/ml).
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WNV growth kinetics
Multi-step virus growth curves were performed on HeLa cell
monolayers in 24-well plates by infecting at an MOI of 0.01 with wt
WNV or each WNV NS1 mutant. Following 1 h of virus attachment,
cells were washed and overlaid with 1ml of 1þ1þ1 MEM medium.
Virus containing supernatants were collected every 24 h for 96 h and
stored at 80 1C prior to titration on Vero cells.
TLR3 signaling in WNV-infected HeLa cells
TLR3 signaling in WNV-infected HeLa cells was assessed
following pIC stimulation. HeLa cells were infected for 1 h at an
MOI of 5 with wt WNV or each WNV NS1 mutant. Virus inoculum
was removed, cells were washed with PBS, and medium was
replaced with 1X DMEM medium containing 10% FBS. Twenty
hours post-infection medium was removed and replaced with 1X
DMEM containing 10% FBS with or without 20 mg/ml pIC and
allowed to incubate for an additional 8 h. IL-6 was quantiﬁed by
ELISA. The proportion of infected cells was assessed 28 h post-
infection by ﬂow cytometry to detect the E protein (described
above).
Statistical analyses
Distribution of each data set was determined by Kolmogorov–
Smirnov test (KS). Student's t test was employed to determine
signiﬁcance when data were normally distributed and Mann-
Whitney U test was performed when data were not normally
distributed. Each test was completed using the statistical software
package, GraphPad Prism 4.
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